9.41
-0.01(-0.11%)
Currency In USD
| Previous Close | 9.42 |
| Open | 9.39 |
| Day High | 9.62 |
| Day Low | 9.3 |
| 52-Week High | 25 |
| 52-Week Low | 3.2 |
| Volume | 13,766 |
| Average Volume | 58,818 |
| Market Cap | 182.56M |
| PE | -3.75 |
| EPS | -2.51 |
| Moving Average 50 Days | 9.39 |
| Moving Average 200 Days | 8.11 |
| Change | -0.01 |
If you invested $1000 in NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) since IPO date, it would be worth $977.15 as of March 12, 2026 at a share price of $9.41. Whereas If you bought $1000 worth of NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) shares 6 months ago, it would be worth $897.04 as of March 12, 2026 at a share price of $9.41.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
NeOnc Technologies Reports Phase 1 Dose-Escalation Results for Dosing and Toxicity and Determination of Recommended Phase 2 Dose for Oral NEO212; Management to Host KOL Conference Call Today at 9 a.m. ET
GlobeNewswire Inc.
Mar 04, 2026 1:00 PM GMT
CALABASAS, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) (“NeOnc” or the “Company”), a multi-Phase 2 clinical-stage biopharmaceutical company developing novel therapies for central nervous system (CNS)
NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Dose-Escalation Results from Full Phase 1 NEO212-01 Readout for Dosing and Toxicity
GlobeNewswire Inc.
Feb 27, 2026 2:00 PM GMT
CALABASAS, Calif., Feb. 27, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) (“NeOnc” or the “Company”), a multi-Phase 2 clinical-stage biopharmaceutical company developing novel therapies for central nervous system (CNS) c
NeOnc Technologies Secures Strategic PIPE Investment led by $10 Million Investment from Cinctive Capital Management
GlobeNewswire Inc.
Jan 30, 2026 2:00 PM GMT
Investment led by Cinctive Co-Founder Richard Schimel underscores institutional confidence in NeOnc’s biotech pipelineCALABASAS, Calif., Jan. 30, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) (“NeOnc” or the “Company”),